Skip to Main Content
Contribute Try STAT+ Today

Riding a wave of consolidation in virtual care, home diagnostics brand Everly Health on Thursday acquired fertility startup Natalist, becoming the latest home testing business to bulk up its lineup with services geared at women and families.

While financial details of the deal were not disclosed, the all-cash transaction parallels an earlier deal between digital pharmacy Ro and testing startup Modern Fertility that brought services including hormone testing and prenatal vitamins into Ro’s broader virtual fold, which was originally focused around treatments for erectile dysfunction and hair loss.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment